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Abstract
All mammals are born ignorant to the existence of microorganisms. Soon after birth, however,
every mammal begins a lifelong association with a multitude of microbes that lay residence on the
skin, mouth, vaginal mucosa and gastrointestinal (GI) tract. Approximately 500-1000 different
species of microbes have highly evolved to occupy these bodily niches, with the highest density
and diversity occurring within the intestine 1. These organisms play a vital role in mammalian
nutrient breakdown and provide resistance to colonization by pathogenic microorganisms. More
recently, however, studies have demonstrated that the microbiota can have a profound and long-
lasting effect on the development of our immune system both inside and outside the intestine 2.
While our immune system has evolved to recognize and eradicate foreign entities, it tolerates the
symbiotic microorganisms of the intestine. How and why this tolerance occurs has remained
unclear. Here we present evidence that the commensal microbes of the intestine actively induce
tolerant responses from the host that coordinate healthy immune responses. Potentially, disruption
of this dialogue between the host and microbe can lead to the development of autoimmune
diseases such as inflammatory bowel disease (IBD), rheumatoid arthritis (RA), or Type I diabetes
(TID). As a wealth of publications have focused on the impact of the microbiota on intestinal
immune responses and IBD, this chapter will focus on the extra-intestinal impacts of the
microbiota from development to disease and integrate the known mechanisms by which the
microbiota is able to actively communicate with its host to promote health.
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Acquisition of the microbiota
Mammalian mucosal surfaces represent a rich microbial habitat. An astounding 100 trillion
of these microorganisms live within our gastrointestinal tract, with densities and diversity of
microbes increasing from the stomach to the colon. Because these organisms outnumber
host cells by an order of magnitude, many have proposed that mammals should be
considered ‘super-organisms’ composed of both mammalian and microbial cells where the
two are intimately linked for health 3.
From birth mammals begin to acquire a consortium of microorganisms from their
environment, many of which will maintain lifelong relationships with their hosts. The
identity of these microorganisms is only beginning to be understood by sequencing 16S
ribosomal DNA from human fecal samples. A study performed by Relman and colleagues
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sampled 14 human infants, including a pair of di-zygotic twins, over the first year of life to
lend insight into the temporal patterns and composition for the assembly of the microbiota 4.
The overall density of bacteria was relatively unstable throughout the first week of life and
then persisted to about 109- 1010/g of stool. The one infant delivered by caesarean section
had lower densities of bacteria, suggesting that mode of delivery is important in acquisition
of microbial organisms. The infants' microbial community varied significantly between
individuals with the exception of the fraternal twins, who had a higher similarity in their
temporal patterns of microbial acquisition. The earliest colonizers were aerobes such as
Staphylococcus and Streptococcus species whereas anaerobic bacteria, such as Eubacteria
and Clostridia appeared later. Additionally, the appearance and disappearance of several
other taxa, including Prevotella and Veillonella was noted. Despite the extreme variation
early in life, a profile characteristic to an adult microbiota type was seen by the end of the
first year. Studies performed on three human adults identified 395 phylotypes at the strain
level and a single Archaeal phylotype. The major species found include the genera
Bacteroides, Eubacterium, Clostridum and Ruminococcus 5. Approximately 80% of the
sequences from these three individuals, represented species that have not yet been
cultivated, demonstrating how little is known regarding the composition of the microbiota.
As was reported with infants, analysis indicated that microbial composition was extremely
variable between individual. Microbial diversity on the planet as a whole is quite diverse,
with 55 divisions of Bacteria and 13 divisions of Archaea described and potentially many
more to discover. Despite the astounding bacterial diversity of the outside world, the human
intestine is dominated by only 2 divisions of bacteria, the Bacteroidetes and the Firmicutes
and one member of the Archaea 6. That such an exclusive group of microorganisms are
given residence, suggests that the relationship between these bacteria and their host is a
specific one, with both the bacteria and host shaping the evolution of their respective
partners. Questions of how bacteria are ‘selected’ (or chose) to live within a given host and
whether each species has a specialized niche remain unanswered, but will certainly be
important endeavors of future investigations.
Can the microbiota shape the development of the extra-intestinal immune
environment?
The development of animals that lack colonization by any microorganism, referred to as
germ-free animals, have allowed for the understanding of how profoundly the microbiota
impacts the development of the host. Commensal organisms have significant affects on the
development of intestinal tissues and cells types and these developmental defects have been
extensively reviewed elsewhere 2, 7. Interestingly, germ-free mice have several extra-
intestinal defects as well, suggesting that the microbes harbored within the GI tract are
capable of shaping systemic immunity 8. The spleen serves as one of the primary
immunologic organs that surveys the blood for the presence of foreign entities. B and T cells
collect within this organ to form an organized structure, with dendritic cells, macrophages
and natural killer (NK) cells also present. In the absence of microbial colonization mice have
fewer and smaller germinal centers within the spleen and fewer gamma-globulin containing
cells 9. Additionally, a study published over 30 years ago found that immunoglobulin G
(IgG) and IgM antibody response of germ-free mice in the spleen is deficient when
challenged with DNP-BSA 10. In this same study, lymphocytes isolated from the spleen had
an attenuated response to the T cell mitogen, ConA, demonstrating that both T and B cell
reactions are impaired in the absence of microbial colonization. Later it was reported that the
number of CD4+ T cells residing within the spleen was two-fold lower in germ-free mice
and produced more interleukin-4 (IL-4) when compared to conventionally colonized
animals, indicating that germ-free mice have a Th2 bias 11. The influence of the microbiota
extends beyond development and guides functional aspects of systemic immunity as well.
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Germ-free mice are more susceptible to infectious pathogens such as Shigella flexneri,
Bacillus anthracis, and Leishmania 2. In a study using a systemic challenge of Listeria
monocytogenes, it was demonstrated that germ-free mice had increased bacterial burden in
the liver, spleen and peritoneal cavity 12. Moreover, trafficking of T lymphocytes to the
peritoneal cavity in response to Listeria infection was impaired in germ-free mice,
suggesting that the microbiota is important for the proper function of the adaptive response
upon infection.
The intestinal immune system goes to great lengths to ensure that the microbes harbored
within the GI tract do not escape to the systemic compartment. In addition to barrier
defenses such as a thick mucus layer and the production of anti-microbial peptides by
intestinal epithelial cells, dendritic cells that take up commensal organisms are unable to
penetrate past the mesenteric lymph nodes and elicit an IgA response to further prevent
commensals from breaking through the intestinal barrier 13. Given the strict restriction of
commensal bacteria to the intestinal lumen, it remains unclear how these organisms could
affect systemic responses and immunity. Additionally, commensal microorganisms are
found at other sites in the body and could therefore be responsible for the systemic effects
seen in germ-free mice. A direct demonstration that a commensal organism residing within
the intestine is capable of coordinating T cells responses in the spleen was shown when
germ-free mice were mono-associated with the prominent human commensal, Bacteroides
fragilis 14. Mono-association with B. fragilis restores the reduced CD4+ T cell numbers and
induces production of the Th1 cytokine interferon-γ (IFN-γ), thereby correcting the Th2 bias
seen in germ-free mice. More importantly, this activity is associated with a single molecule
made by B. fragilis, polysaccharide A (PSA). Indeed, mono-association of mice with a
mutant of B. fragilis that lacks expression of PSA (B. fragilisΔPSA) does not correct the
systemic CD4+ T cell defect. These data demonstrate that individual species of the intestinal
microbiota can influence extra-intestinal immune responses and present the possibility that
these organisms can influence systemic diseases.
Communicating with the microbiota
Pathogen manipulation of host immunity has been a major scientific focus over the last
couple of decades. However, mammals are host to a diverse consortium of bacteria to which
we remain immunologically tolerant. Since pathogens and commensals have many of the
same motifs that elicit immunity within the host, how the host tolerates this extraordinary
bacterial burden while maintaining the ability to mount productive immunity towards
pathogens has remained enigmatic. Initially, studies suggested that the host was largely
unaware of the presence of their microbial guests. However, emerging evidence suggests
that rather than being ignorant, the host is actively tolerating the commensal consortium of
intestinal organisms. The mechanisms that govern this tolerance remain largely unknown.
We propose that the host is not the only participant in directing immune responses, but
rather that an active dialogue occurs between host and microbe that results in a relationship
that has benefits to both parties. The words of this communication come in the form of
specific bacterial and host molecules that can coordinate the biology of both participants.
Here we will review the mechanisms by which the host senses the microbiota and in turn the
signals utilized by commensal organisms to coordinate tolerogenic host responses (Table 1).
The mammalian immune system can be divided into two major arms; innate and adaptive
immunity. The innate immune system is built upon the sensing of conserved microbial
associated molecular patterns (MAMPs) such as cell wall components of bacteria by Toll-
like receptors (TLRs) and Nod-like receptors (NLRs) found on numerous cell types
including macrophages, dendritic cells and even T cells. Following ligand binding, TLRs
initiate signal transduction cascades that begin with adaptor proteins of the MyD88 family,
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and culminate in widespread changes in gene expression including induction of NF-κB.
TLRs regulate a variety of different genes, including those that function as transcriptional
activators, immunomodulatory cytokines, regulators of phagocytosis, mediators of antigen
presentation and co-stimulation, and managers of cell proliferation. This represents the first
wave of an immune response. Activated innate immune cells, such as DCs, will then elicit
induction of the adaptive arm of the immune response which includes the activation of
antigen specific T and B cells. The T helper cell response is fine-tuned for the type of
pathogen encountered, and can consist of 4 lineages characterized by the expression of
specific proteins. T helper 1 (Th1) cells produce large amounts of IFN-γ, while Th2 cells are
marked by IL-4 secretion. Th17 cells make copious amounts of IL-17 and have recently
been implicated in multiple autoimmune diseases. Finally, regulatory T cells (Tregs)
represent a lineage of helper T cells that suppress immune responses, either by directly
down-regulating T cell activity or suppressing cells of the innate immune system. These cell
types are characterized by the expression of the transcription factor Foxp3 and secrete
suppressive cytokines such as IL-10 and transforming growth factor- β (TGF-β) 15. While
the innate immune system utilizes TLRs and NLRs to directly recognize the presence of
bacteria, the adaptive immune system recognizes bacterial specific antigens via T and B cell
receptors. Thus, each lineage is capable of maintaining a dialogue with the microorganisms
itself.
The intestine represents one of the largest mucosal surfaces on the human body. As such,
defending this area against microbial penetration is a complicated task and involves multiple
cell types. Intestinal epithelial cells (IECs) form a single cell barrier between the lumen of
the intestine preventing access to the rest of the body. Thus, IECs represent the frontline of
defense against the invasion of microorganisms as well as the first-line of communication.
As an initial defense to the entry of microorganisms, specialized cells types within the
epithelial layer secrete mucins that help form a thick protective layer over the IECs 16.
Indeed, this mucus layer has been shown to be devoid of bacteria and thus functions to limit
penetration of microbes within the intestinal wall 17. Despite this barrier, IECs still come
into contact with luminal bacteria and must respond accordingly. Therefore, it is no surprise
that IECs express both TLRs and NLRs. Some of these receptors, such as TLR4, are
expressed at low levels of IECs while others, such as TLR5 are expressed normally 18.
Accordingly, IECs have been reported to be hyporesponsive to LPS, potentially explaining
why these cells can tolerate the large bacterial burden within the intestine. However, feeding
mice purified LPS was sufficient to induce the expression of the anti-microbial peptide
RegIIIγ, demonstrating that IECs are capable of responding to LPS within the lumen of the
intestine 19. If IECs are capable of mounting inflammatory responses to Toll ligands, how is
tolerance achieved? A seminal study from Medzhitov and colleagues reported that MyD88
deficient animals are severely susceptible to intestinal injury 20. Indeed, this study
demonstrated that TLR signaling elicits the production of tissue protective factors that are
imperative for intestinal homeostasis and suggested that TLR signals in the intestine may not
always elicit inflammation. More importantly, they demonstrated for the first time that
commensal organisms within the intestine may actively guide host protective responses.
Supporting this, IEC specific inhibition of NF-κB (a pathway induced by TLR signaling)
through conditional ablation of NEMO results in spontaneous and chronic intestinal
inflammation 21. Long before these studies had been performed, germ-free mice had been
reported to have a slower rate of epithelial cell turnover, further validating the idea that
commensally derived signals are important for intestinal integrity. Not only have commensal
bacteria been implicated in IEC homeostasis, but these organisms can also control IEC cell
signaling. Pathogenic Salmonella enterica was co-incubated with the commensal organism
Bacteroides thetaiotaomicron on intestinal epithelial cells and a cDNA array was used to
monitor inflammatory responses 22. While S. enterica alone initiated strong expression of
inflammatory mediators such as IL-8 and tumor-necrosis factor (TNF), co-incubation with
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the commensal organism B. thetaiotaomicron down-regulated this inflammatory activity.
Interestingly, the ability of B. thetaiotaomicron to suppress S. enterica-induced
inflammation was specific, as a related strain, Bacteroides vulgates did not produce the same
attenuating effect. The mechanism by which B. thetaiotaomicron suppresses inflammation
was through enhancing the nuclear export of the transcription factor NF-κB. Inhibition of
NF-κB signaling in IECs was also demonstrated for a non-pathogenic Salmonella strain 23.
The anti-inflammatory effect could be abolished by non-denaturing heat killing of the
organisms and was not present in bacterial lysates or conditioned media suggesting that the
anti-inflammatory effect of this strain was mediated through direct interactions of the
epithelium with viable bacteria. In contrast, media supernatants from a mix of several
Lactobacillus and Bifidobacteria strains have been shown to enhance epithelial cell
integrity24. Therefore, while IECs are equipped with the ability to mount inflammatory
responses toward bacteria, it seems that the enteric flora express specialized molecules to
coordinate a tolerant host response. The identity of these molecules produced by the bacteria
and the receptors to which these molecules associate remain completely unknown.
Mucosal dendritic cells (DCs) are known to sample luminal contents and thus represent a
second cell type that is in direct contact with the commensal microbiota. Dendritic cells
bridge innate and adaptive immunity by directly responding to bacterial presence through
the expression of TLRs and NLRs, and subsequently presenting bacterial antigens to T cells.
Within the intestine, DCs have been shown to induce largely tolerogenic T and B cell
responses. Indeed, TNF-α and iNOS expressing DCs induce T cell independent IgA
secretion from B cells, which limits penetration of commensal organisms past the epithelial
barrier 25. The second mechanism by which these cell types elicit tolerance is through the
induction of regulatory T cells (Treg). CD103+ DCs have been identified to reside within
the mesenteric lymph nodes (MLNs) and convert a naïve T lymphocyte into a Treg with
functionally suppressive capacity 26, 27. These data indicate that specialized DCs exist
exclusively within the intestine and function to maintain tolerance. While it is unclear to
what extent the microbiota influences the development of CD103+ DCs, studies looking at
CD11c+ cells in the MLN suggest the DCs derived from germ-free mice are fewer in
number and are less able to stimulate T cell responses, indicating that the microbiota can
influence DC function 28. Supporting this, bone marrow derived dendritic cells (BMDCs)
incubated with commensal Lactobacillus species are able to induce Treg responses 29.
Additionally, transfer of Lactobacillus-treated DCs prevented intestinal inflammation in a
MyD88 and TLR2 dependent manner, suggesting that bacterial molecules are capable of
being recognized by DCs and coordinating their tolerogenic potential.
Tregs are considered one of the dominant mechanisms of tolerance induction within
mammals, and have indeed been shown to be paramount for the maintenance of intestinal
homeostasis. Indeed, transfer of effector T cells in the absence of Tregs elicits robust and
chronic intestinal inflammation while co-transfer of effector T cells with Tregs ameliorates
disease 30. Additionally, Treg specific ablation of IL-10 results in spontaneous intestinal
inflammation, but not systemic autoimmunity, indicating that specific subsets of Tregs
function to maintain homeostasis within the intestine 31. A few reports have indicated that
the microbiota can influence the development of T regulatory subsets, though others have
reported contradictory results 7. Demonstrating that microbial recognition can influence the
development of Tregs, a recent study demonstrated that TLR9 deficient animals have an
increased frequency of Tregs at intestinal sites 32. Specific commensal bacteria residing
within the intestine have been shown to influence the development of Tregs in systemic
compartments. Bifidobacteria infantis can increase the numbers of CD4+Foxp3+ Tregs in
the spleen. Further, transfer of B. infantis-induced Tregs can inhibit pro-inflammatory NF-
κB activity 33. Additionally, Lactobacillus strains have been demonstrated to induce IL-10
independent tolerogenic responses, suggesting that multiple commensal bacteria have
Round et al. Page 5
J Autoimmun. Author manuscript; available in PMC 2011 August 12.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
evolved mechanisms to induce T regulatory cells within the intestine. Molecules from these
organisms that direct the development of Treg cells have not yet been identified. It has
recently been demonstrated that a single capsular polysaccharide, PSA, from the prominent
human commensal, Bacteroides fragilis, is able to protect from experimental colitis through
the induction of IL-10 producing tolerogenic T cells 34. The ability of PSA to influence host
T cell biology has been demonstrated to act through presentation of PSA on MHCII by an
antigen presenting cell 35, demonstrating that microbial antigens can indeed direct host
immune responses and represents another level of communication that can be utilized by the
microbiota. It seems likely that the mechanisms by which Treg biology is influenced by the
commensal bacteria is through the direction of DCs. Therefore, it is likely that commensal
microbial antigens are being presented to either naïve T cells for conversion into Treg cells
or directly being presented to the Tregs themselves. An alternative mechanism by which the
microbial consortium could influence Treg biology is through the engagement of TLRs.
While this is a fairly unexplored area of research, one report demonstrating that Myd88
deficient Tregs are unable to protect from experimental intestinal inflammation offers the
possibility that TLR ligands can directly govern Treg biology 36. Recent data indicate that
proper Treg homeostasis requires production of small single stranded RNAs called miRNAs.
Although several miRNAs are likely involved in Treg biology, mice genetically deficient in
a single miRNA, miR-155, have reduced Treg numbers due to a lack of overall fitness 37.
Interestingly, miR-155 expression levels are known to be modulated following immune
stimulation by microbial ligands. This suggests that commensal flora might influence
miRNA expression in host immune cells, such as Tregs, that are important for regulating
overall immune homeostasis.
The identification of PSA as a molecule able to induce tolerogenic responses, suggests the
possibility that commensal bacteria have evolved specialized molecules in order to
coordinate their own tolerance within the intestine. Pathogens have evolved specialized
proteins to subvert or control host immunity to enhance infectivity. Perhaps commensals
have also evolved mechanisms to coordinate their ability to colonize a given host.
Understanding what the microbial tools of communication are and in turn how the host can
understand this message will be imperative to our understanding of host-microbial mutalism.
Autoimmunity: when the dialogue becomes interrupted
The hygiene hypothesis was first proposed 20 years ago to explain the dramatic rise in
atopic diseases seen over the preceding decade 38. This hypothesis posits that the aberrant
immune responses such as allergy are a result of smaller family sizes and improvements in
personal cleanliness which have reduced the exposure to microbial stimulation. An
extension of this hypothesis is the ‘microflora hypothesis’ or altered microbiota hypothesis
proposed by Noverr and Huffnagle 39. This hypothesis proposes that changes in the
gastrointestinal microbiota because of antibiotic use and dietary differences in developed
countries have disrupted the normal microbial mediated mechanisms of immunological
tolerance. There is a significant amount of epidemiologic and clinical data to support the
altered microflora hypothesis 39. Both of these hypotheses make two critical points: 1) that
the environmental changes can impact the microbiota and 2) that this perturbation in the
composition of the microbiota can lead to disease. Several studies have explored the idea
that antibiotics can disrupt the composition of the microbiota. Relman and colleagues used
pyrosequencing technology to generate large numbers of 16S rDNA tags from fecal samples
taken from three individuals before and after ciprofloxacin treatment 40. They found that
treatment with antibiotics reduced the diversity of the microbiota with significant impacts on
over one-third of the community. The microbiota closely resembled that of the pretreatment
state within 4 weeks, however, several taxa failed to recover within 6 months. These data
demonstrate that antibiotics can have devastating consequences to the composition of the
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microbial community, many of which might be permanent. One consequence of broad
spectrum antibiotic therapy is the colonization of the host by antibiotic resistant pathogens,
an example of which is vancomycin resistant Enterococcus (VRE). It has been unclear how
antibiotic mediated depletion of commensal organisms allows for colonization by VRE. A
recent study demonstrated that mice given a course of antibiotics have reduced expression of
the C-type lectin, RegIIIγ 19. RegIIIγ is known to kill gram-positive bacteria, such as VRE,
and is induced by intestinal gram-negative symbionts such as B. thetaiotaomicron 41. Thus,
antibiotic treatment can compromise the microbial induced mechanisms of host bacterial
killing and thereby allow pathogenic bacteria an opportunity to colonize. Together, these
data support the notion that antibiotics can have severe impacts on the composition of the
microbial community.
The second supposition of the altered microbiota hypothesis is that a change in the
composition of the microbial community can lead to disease. Several reviews have discussed
the extensive evidence for the role of the microbiota in intestinal inflammatory
autoimmunity 7. Here we discuss the evidence for the involvement of commensal bacteria in
systemic immune aberrations including allergy, rheumatoid arthritis (RA) and type I
diabetes (T1D).
The hygiene hypothesis was originally formulated in response to the dramatic increase in the
incidence of allergies. Since its inception, at least 14 reports containing over 2,000
individuals have been published that demonstrate the correlation between allergy and an
altered microbiota 8. In most of the studies, a decrease in Bifidobacteria preceded the
development of allergy. Additionally, higher counts of Clostridial species, such as
Clostridium difficile, were found to be associated with development of allergies. While
many of these correlations are compelling, it is difficult to assess whether these changes in
microbial composition are causative. To do this, a defined animal model to study allergy is
required. The majority of murine models of allergic airway disease use systemic
sensitization prior to intranasal challenge, however allergies in humans do not arise from
immunization with an allergen. Therefore, there are currently no suitable animals models to
explain how allergen sensitization can occur in the absence of systemic challenge or to test a
role for the microbiota in allergy development. In response to this Huffnagle and colleagues
have developed a mouse model of allergic airway disease that results from antibiotic therapy
and microbial disruption 42. Immunocompetent animals are treated for 5 days with
cefoperazone in the drinking water followed by a single oral gavage of Candida albicans.
This leads to a stable increase in the fungal microbiota and alteration of the commensal
intestinal bacteria. These mice are then exposed to an intranasal challenge of an allergen
derived from Aspergillus fumigatus spores. Interestingly, in an environment where the
natural intestinal microbiota is disrupted, introduction of a common allergen to the lungs
results in T cell mediated airway autoimmunity. The development of this model has several
important implications. It directly demonstrates that allergy can develop when the
microbiota becomes disrupted and provides a platform for manipulation of particular
commensal species to determine their individual impact on the development of allergy.
Future studies should identify specific commensal species that can prevent allergy induction
and the mechanisms by which these organisms accomplish this.
Rheumatoid arthritis is a disabling musculoskeletal autoimmune disease whose fundamental
causative factors remain unknown. It is widely accepted that both genetic and environmental
predisposing factors are involved; however, disease heritability is estimated to be between
only 50-60%. This indicates that environmental factors play an important role in RA
development 43. Several observations have lead to the idea that the intestinal microbiota
might be involved in disease induction. In patients with inflammatory arthritis, degradation
products of bacterial cell walls and nucleic acids are detected in inflamed joints. Moreover,
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injection of bacterial cell wall fragments from several intestinal commensals have been
shown to induce arthritis 44. This has led investigators to look at the composition of the
intestinal microbiota of patients with early RA. The results of this study indicate that
patients with RA had significantly less Bifidobacteria species, bacteria of the Bacteroides-
Porphyromonas-Prevotella group and Bacteroides fragilis subgroup, supporting the notion
that the intestinal microbiota is altered during disease 45. Supporting the notion that the
microbiota plays a role in RA development an animal model of Collagen induced arthritis
was used. Disease was induced in germ-free and conventional animals were induced and
progression of the RA development monitored. Interestingly, germ-free animals had
markedly worse disease than animals with a complex microbiota, demonstrating that the
microbiota has a suppressive effect on the development of RA 46. This indicates that there
are organisms within our intestine that are mediating beneficial immune responses that
potentially actively suppress the development of joint inflammation.
Type I diabetes is an autoimmune disease that results from the T cell mediated destruction of
insulin-producing β cells. The incidence of TID has steadily increased over the past several
decades in developed countries suggesting an environmental component to disease
induction 47. Supporting this, incidence of disease in experimental animal model systems
varies with the microbial status of the housing facility 48. Moreover, diabetes development
in the non-obese diabetic (NOD) mouse model is increased when mice are re-derived in a
germ-free environment. Because TLRs are receptors that are known to recognize bacteria, a
recent study set out to understand how microbial sensing impacted the progression of T1D.
To do this, NOD mice were crossed with Myd88 deficient animals and disease monitored 49.
While wild-type NOD mice developed diabetes as early as 10 weeks, MyD88 deficient
animals were completely devoid of autoimmunity, suggesting that microbial signals initiate
disease. However, when these animals are rederived in a germ-free environment the
incidence of disease dramatically increases, suggesting that the presence of the microbiota is
protective even in the absence of signaling by TLRs. Therefore in this scenario, bacterial
sensing by TLRs enhances the development of TID, while mechanisms that do not require
TLRs induce protective responses. Although there has not been a reported connection
between commensal microbiota and the autoimmune conditions multiple sclerosis (MS) or
lupus, a few TLR pathways have been shown to reduce disease severity in specific mouse
models. For instance, engagement of TLR9 reduces disease in lupus, and a TLR-dependent
tolerance mechanism in B cells blunts T cell mediated tissue damage in MS. While TLR
engagement on cells generally leads to production of pro-inflammatory cytokines, it also
induces certain anti-inflammatory molecules, like IL-10, which may be at the heart of TLR
dependent mechanisms of tolerance in autoimmune settings. Because TLRs can recognize
motifs that are found on commensal bacteria, it is plausible that TLRs can link commensal
microbes to both lupus and MS as well. To truly understand the mechanisms of how the
microbiota influences immune health and development of these various autoimmune
diseases, it will be critical to have good animal model systems where the composition of the
microbiota can be manipulated. While most of what is known about microbial mediated
tolerance comes from studies performed in IBD, these examples lend evidence that the
communication between the host and microbe is imperative to host health and suggest that
the microbiota could have impacts on a multitude of other human diseases.
Conclusion
The complex consortium of microbes that we harbor within our gastrointestinal tract are not
just passive bystanders, rather these organisms seem to actively shape our immune system
responses both inside and outside the intestine. The multiple diseases that have been
suggested to be associated with a disruption in the commensal microbiota highlight the
importance of understanding the individual species that make up a ‘healthy’ microbiota.
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While it seems clear that the microbiota influences disease progression and/or prevention,
the mechanism by which it can accomplish this task remain completely unknown. We have
presented evidence that there is an intimate communication between host and microbe that
involves bacterial molecules and host derived sensors. While much of the data to date has
explored TLRs and NLR receptors as the bacterial communication devices, there is evidence
that alternative means, such as presentation of enteric bacterial derived molecules by DCs,
can influence immune responses that affect autoimmunity. The focus of future endeavors
will be to identify these molecules as well as the host receptors that recognize them, as
beneficial microbial products could offer new therapeutics to enhance human health.
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Table 1
Tolerogenic responses utilized by the host that are either genetically encoded by the host or induced by the
bacteria themselves
Cell Type Host response Bacteria Mechanism
Epithelial cells
RegIIIγ B. thetaiotaomicron unknown
hyporesponsive to LPS ↓ expression of TLR4
barrier integrity Bacteria Myd88 signaling
↓IL-8 and TNF-a B. thetaiotaomicron ↓ NF-κB
↓ inflammation nonpathogenic Salmonella inhibit IkBa degradation
barrier integrity Lactobacillus/Bifidobacteria secreted protein factor
barrier integrity B. breve secreted factor
Dendritic cells
IgA from B cells TNF-α, iNOS, April, BAFF
CD103+ Tregs Induction of Tregs
↓ inflammatioin Lactobacillus DC induced Tregs
 Tregs
B. infantis induction of Tregs
Lactiobacillus rhamnosus GG Induction of Tregs
B. fragilis IL-10 expressing T cells
VSL#3 TGF-β + Tregs
 B cells
intestinal homeostasis Bacteria IgA
↓ sytemic abs to commensals unknown MyD88 signaling
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